How to Manage Risk in Speculative Biotech Stocks
April 24, 2018 at 06:19 AM EDT
Biotech IPOs are a special animal. Not only are the companies usually not profitable, but most of the time they don’t even have a product on the market yet.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|